XML 24 R18.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders' Equity
 9 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Stockholders' Equity

NOTE 10 – STOCKHOLDERS’ EQUITY

The Company is authorized to issue 5,000,000 shares of preferred stock, par value at $0.001 per share and 100,000,000 shares of common stock, $0.001 per share. No shares of preferred stock are issued or outstanding on March 31, 2025 or June 30, 2024.

Common Stock

In December 2023, the Company’s board of directors authorized the repurchase of up to 5,000,000 shares of the Company’s common stock through December 31, 2025. In February 2022, the Company’s board of directors authorized the repurchase of up to 5,000,000 shares of the Company’s common stock through December 31, 2023. Under the stock repurchase programs, the Company is authorized to repurchase, from time to time, shares of its outstanding common stock in the open market at prevailing market prices or through privately negotiated transactions as permitted by securities laws and other legal requirements. The programs do not obligate the Company to repurchase any specific number of shares and could be suspended or terminated at any time without prior notice. Under these repurchase programs, the Company purchased 129,360 shares of its common stock at an average cost of $5.47 per share for an aggregate cost of $708, and 532,401 shares of its common stock at an average cost of $5.79 per share for an aggregate cost of $3,081 during the nine months ended March 31, 2025 and 2024, respectively.